Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Liver International : Official Journal of the International Association for the Study of the Liver|April 24, 2014
Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liverPilar Alzuguren, Sandra Hervas-Stubbs, Gloria Gonzalez-Aseguinolaza, et al.
The Journal of Clinical Investigation|May 16, 2023
Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndromeSaja Fadila, Bertrand Beucher, Iria González Dopeso-Reyes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cellsErica M Gomes, Margret S Rodrigues, Anagha P Phadke, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2022
High value of 64Cu as a tool to evaluate the restoration of physiological copper excretion after gene therapy in Wilson's diseaseOihana Murillo, Maria Collantes, Cristina Gazquez, et al.
Gene Therapy|July 22, 2024
Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profilesMaría Bunuales, Angeles Garduno, Miguel Chillon, et al.
Journal of Hepatology|September 27, 2015
Long-term metabolic correction of Wilson's disease in a murine model by gene therapyOihana Murillo, Daniel Moreno Luqui, Cristina Gazquez, et al.
Scientific Reports|October 4, 2019
Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutationAna Ricobaraza, Lucia Mora-Jimenez, Elena Puerta, et al.
Hepatology (Baltimore, Md.)|February 2, 2019
Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration of Copper Homeostasis in a Wilson Disease Model in MiceOihana Murillo, Daniel Moreno, Cristina Gazquez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2011
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancerRafaela Argnani, Peggy Marconi, Ilaria Volpi, et al.
The Journal of Gene Medicine|November 25, 2010
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectorsPelagia Foka, Aldo Pourchet, Ruben Hernandez-Alcoceba, et al.
Pageof 5